Table 2.
miRNAs and autophagy in hepatocellular carcinoma cell drug resistance
miRNA | Expression Level in HCC | Effect on autophagy | Involvement in drug resistance | Ref. |
miR26a/b | Downregulated in tissues and cell lines (HepG2, Hep3B, MHCC97-H and SMCC-7721), also by chemotherapeutic drugs and autophagy inhibitors | Inhibited autophagy, by targeting the expression of ULK1, the key initiator of autophagy | Sensitized HepG2 cells and tumors to apoptosis induced by DOX through targeting autophagy | [53,54] |
miR199a-5p | Downregulated in HepG2 and HuH-7 cells and tissues, also by chemotherapeutic drugs | Inhibited cisplatin-induced autophagy, by interacting with the 3’UTR region of ATG7 transcript (an autophagy related gene) | Protected HepG2 and HuH-7 cells from cisplatin-induced resistance | [56,58] |
miR101 | Downregulated in cell lines (SMMC-7721, HepG2, Bel-4404, and 97L) and tissues, associated with distant metastasis and related to poor prognosis | Inhibited autophagy, by reducing STMN1, RAB5A, ATG4D and mTOR expression (involved in the phagosome formation) | Sensitized HepG2 cells to apoptosis induced by cisplatin | [61,62] |
miR216b | Downregulated in patient plasma and tissues, related to poor prognosis | Inhibited autophagy, by targeting . MALAT1 (an oncogenic long non-coding RNA generally upregulated in HCC that modulates chemosensitivity) | Sensitized BEL-7402/5-FU resistant cells to 5-FU-, DOX- and mitomycin-induced death | [65,66] |
miR142-3p | Downregulated in tissues, also by sorafenib treatment | Inhibited sorafenib-induced autophagy by binding to the 3’-UTR of ATG5 and ATG16L1 | Sensitized SMCC-7721 and HepG2 cells to sorafenib-induced death | [69,70] |
miR21 | Overexpressed in patient tissues and in drug-resistant cells | Inhibited autophagy, and downregulated PTEN pathway | miR21-dependent autophagy inhibition contributed to sorafenib resistance in Huh7 and HepG2 cells and HCC tumors developed in mice | [72-74] |
miR423-5p | Overexpressed in tissues, also elevated in serum of sorafenib-treated patients, and secreted in high levels from sorafenib-treated cells | Induced autophagy | Proposed as a helpful tool to predict patient response to sorafenib treatment | [77,78] |
miRNA: MicroRNA; HCC: Hepatocellular carcinoma; ULK1: Unc-51 like autophagy activating kinase; DOX: Doxorubicin; 3’-UTR: 3’-untranslated region; ATG: autophagy-related protein; STMN1: Stathmin 1; RAB5A: RAS related protein; ATG4D: autophagy-related 4D cysteine peptidase; mTOR: The mammalian target of rapamycin; MALAT1: Metastasis associated lung adenocarcinoma transcript 1; 5-FU: 5-Fluoroacil; PTEN: Phosphatase and tensin homologue.